MAP2 antibody and other neural markers: what each labels in nervous tissue

Neural tissue is where marker antibodies are most often over-read, because a label that marks a compartment gets reported as marking a cell type and a label that rises with activation gets reported as marking cell number. These four are widely used, each reports something specific, and each has a preparation that makes or breaks it.

the two retrieval buffers worth testing on any new marker
pH 6 / pH 9
the containment human nervous tissue is handled at
BSL-2
the authentication guidance a funded study is expected to follow
NIH rigor

Figures in this panel are the validation and labelling rules a research antibody is bought and used under, named from the guidance itself and linked in the sources below. They are identifiers, not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a reagent price index it has not measured.

What each marker reports, from an oligodendrocyte marker to a neuronal one

  1. MAP2 labels the somatodendritic compartment. It marks the cell body and dendrites and excludes the axon, which is precisely what makes it useful for distinguishing dendritic from axonal processes in culture. It is not a count of neurons and it is degraded by ischaemia, so post-mortem interval matters in tissue.
  2. Nestin marks progenitors and reactive states, not a lineage. An intermediate filament of neural progenitors that is re-expressed in reactive astrocytes and in endothelium. Reporting nestin as a progenitor count without excluding vessels and reactive glia is a common overreach.
  3. NeuN is a nuclear neuronal marker with known exceptions. It labels most neuronal nuclei and is the usual denominator for neuronal counts, and there are well documented neuronal populations it does not label. Where the count matters, state which populations were counted rather than implying all neurons.
  4. SOX10 is a nuclear glial and neural crest marker. Nuclear staining makes it straightforward to count, which is its practical advantage over cytoplasmic glial markers. It also marks melanocytic lineage, which matters in tumour work.
  5. Test retrieval before changing antibody. Nuclear markers generally need heat induced retrieval and cytoskeletal ones frequently do not, and over-fixed archival tissue needs harder conditions. Run citrate near pH six against a Tris buffer near pH nine on a known positive section before concluding a reagent does not work.

Multiplexing these four on one section

Two nuclear markers and two cytoplasmic ones is a convenient combination because the compartments separate visually even when the channels bleed slightly. Raise the primaries in different hosts so ordinary cross-adsorbed secondaries can separate them.

Brain tissue autofluoresces strongly in the green, largely from lipofuscin and fixation, so put the dimmest marker at a longer wavelength and image an unstained section at the experiment's settings before staining anything.

Post-mortem interval and fixation history

Several neural epitopes degrade with time to fixation, and archival blocks fixed for weeks behave differently from tissue fixed overnight. Record both, because a cohort with inconsistent fixation cannot be compared however good the staining looks.

Where a cohort is already inconsistent, include fixation time as a variable in the analysis rather than hoping it averages out. It rarely does.

Counting honestly

Fix the acquisition settings from a control section, define the region and the threshold before looking at the images, and use a nuclear counterstain as the denominator. Thresholds chosen after seeing the result are the commonest reason a neural count does not replicate.

Where cells are counted in sections, the stereological problem is real: a nucleus split across two sections is counted twice unless the counting rule prevents it. State the rule used.

Which oligodendrocyte markers and neuronal markers separate the lineages

The myelinating lineage is read at three stages and the markers do not overlap: a transcription factor for the precursor, a surface proteoglycan for the immature cell, and a structural myelin protein for the mature one. Reading only the last one makes a tissue look devoid of the lineage when it is full of precursors, which is the commonest misreading of a demyelinating model.

The neuronal set has the same trap in the other direction: a pan neuronal nuclear antigen labels most but not all neurons and is lost in some populations and after injury, so an absence is not evidence of death. Pair a nuclear marker with a cytoskeletal one, and say in the method which structure each antibody labels rather than naming the cell type alone.

A neuron marker panel and what a single stain cannot say

A neuron marker is chosen by what has to be distinguished: a pan neuronal nuclear antigen for counting, a cytoskeletal marker for morphology, a transmitter enzyme for a subtype, and a maturity marker for a stage. Several neuron types express the common markers weakly or not at all, so a count based on one undercounts by a known amount that belongs in the method.

A ptp1b antibody and a phosphatase read by its substrates

PTP1B dephosphorylates receptor kinases and is anchored on the endoplasmic reticulum membrane, so a ptp1b antibody reports expression and localisation while the functional readout is a substrate's phosphorylation. It is oxidised and inactivated reversibly, which means a redox trapping step is what an activity measurement needs rather than an antibody.

Common questions

Does a map2 antibody label axons?
No, and that is the point. It marks the cell body and dendrites and is excluded from the axon, which is what makes it the standard way to distinguish dendritic from axonal processes in culture.
Can I count neurons with a neun antibody?
For most populations, yes, and there are documented neuronal types it does not label. Report which regions and populations were counted rather than implying a total neuronal count.
Is a nestin antibody a progenitor marker?
It marks progenitors and is also re-expressed in reactive astrocytes and in endothelium. A nestin count without excluding vessels and reactive glia overstates the progenitor population.
Why does my staining work in culture and fail in tissue?
Fixation and retrieval. Cultured cells are lightly fixed and accessible; tissue is cross-linked and needs retrieval matched to the epitope. Test two retrieval buffers on a known positive before changing the reagent.
What does a SOX10 antibody label?
Glial and neural crest nuclei. Because the stain is nuclear it is straightforward to count, which is its practical advantage over cytoplasmic glial markers, and it also marks the melanocytic lineage, which matters in tumour work.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/neural-marker-antibodies/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices